Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy Officer
Jennifer Riley WAYNE, Pa. and ROCKVILLE, Md., Jan. 02, 2025 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical...
Therapeutics
PharmAust affirms corporate strategy with name change to Neurizon Therapeutics
MELBOURNE, Australia, Oct. 15, 2024 /PRNewswire/ -- Neurizon Therapeutics Limited (ASX: NUZ) ("Neurizon" or "the Company"), a clinical-stage biotech company dedicated to...
PharmAust affirms corporate strategy with name change to Neurizon Therapeutics
MELBOURNE, Australia, Oct. 15, 2024 /PRNewswire/ -- Neurizon Therapeutics Limited (ASX: NUZ) ("Neurizon" or "the Company"), a clinical-stage biotech company dedicated to...
Aligos Therapeutics Appoints David Perry as Vice President of Business Development
Aligos Therapeutics (Nasdaq: ALGS) has appointed David Perry as Vice President of Business Development, effective...
Stoke Therapeutics Appoints Eric Olson, MS, MBA as Chief Business Officer
– Mr. Olson brings two decades of successful corporate business development experience with an emphasis on rare diseases and RNA...
